Quarterly report pursuant to Section 13 or 15(d)

NOTES PAYABLE (Details Narrative)

v2.4.0.6
NOTES PAYABLE (Details Narrative) (USD $)
 3 Months Ended 63 Months Ended 9 Months Ended 6 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2012
Dec. 31, 2012
Financing Arrangement Directors and Officers Insurance
Dec. 31, 2012
Financing Arrangement Clinical Trial Insurance
Notes payable, amount       $ 48,300 $ 24,438
Notes payable, interest rate       11.50% 12.95%
Principal repaid       48,300 18,900
Interest Paid $ 560    $ 72,300 $ 1,508 $ 869
Issuance date       Mar. 24, 2012 Jun. 30, 2012